Aerial BioPharma is a different kind of drug development company.
NC development team nabs $5M angel tranche for its latest biotech play February 21, 2013Acorda Therapeutics Announces Completion of Neuronex, Inc. Acquisition December 21, 2012Aerial Biopharma Receives FDA Orphan Drug Designation for Narcolepsy Drug in Development August 29, 2012Rex Health Ventures Announces Inaugural Investment in N.C. Firm, Aerial BioPharma July 12, 2012Neuronex Announces Merger Agreement with Acorda Therapeutics February 20, 2012CNS therapies firm Aerial BioPharma launches $12M fundraising round October 21, 2011
Aerial BioPharma is a privately held biopharmaceutical company focused on developing biologics and small molecules for conditions that are affected by processes in the Central Nervous System.
Copyright © 2012, Aerial BioPharma LLC. All Rights Reserved.